CERO (CERo Therapeutics Holdings) General and Admin. Expense : $5.06 Mil (TTM As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. CERo Therapeutics Holdings's General and Admin. Expense for the three months ended in Sep. 2024 was $2.63 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2024 was $5.06 Mil.

CERo Therapeutics Holdings General and Admin. Expense Historical Data

The historical data trend for CERo Therapeutics Holdings's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings General and Admin. Expense Chart

CERo Therapeutics Holdings Annual Data

Trend

Dec21

Dec22

General and Admin. Expense

2.48

2.13

CERo Therapeutics Holdings Quarterly Data
	Dec21	Mar22	Dec22	Mar23	Jun23	Sep23	Mar24	Jun24	Sep24
General and Admin. Expense	Get a 7-Day Free Trial				1.22	0.26	-	2.43	2.63

CERo Therapeutics Holdings General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.06 Mil.

CERo Therapeutics Holdings General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CERo Therapeutics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

201 Haskings Way, Suite 230, South San Francisco, San Francisco, CA, USA, 94080

Website

https://www.cero.bio

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.